Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1981 Aug;40:65–81. doi: 10.1289/ehp.814065

Metal interactions in carcinogenesis: enhancement, inhibition

Gunnar F Nordberg, Ole Andersen
PMCID: PMC1568833  PMID: 7023935

Abstract

Metals constitute a fundamentally important part of the total human environment. Since human exposure often involves complex mixtures of metal compounds and, possibly, organic compounds which may be carcinogenic per se, interactions between these compounds may add significantly to human cancer risk. Our present knowledge about these kinds of interactions is very limited. The best investigated area is benzo(a)pyrene (BP)-metal oxide particle interactions in respiratory carcinogenesis in the hamster. Metal oxide particles were also shown to modify the carcinogenic effect of nitrosamines. Several reports describe experiments in which selenium compounds exerted a generally anticarcinogenic and antimutagenic activity. Inorganic arsenic compounds, which are accepted to be carcinogenic in man, have so far been negative in animal experiments except for one recent suggested report. Several authors have, however, suggested that these compounds may act as cocarcinogens due to their inhibition of DNA repair, although animal experiments to demonstrate a cocarcinogenic effect of arsenic compounds have been negative so far, except for one preliminary report. The concentration of zinc in the diet seemed to influence both transplanted tumor growth and the carcinogenicity of several organic compounds, and the possibility of a correlation between dietary zinc and certain cancer forms in man has been suggested. Protection against development of Leydigiomas usually induced by cadmium injection was afforded by simultaneous injection of zinc salts. Nickel carcinogenesis has been reported to be antagonized by manganese, and synergism between Ni and organic carcinogens, e.g. BP, has been demonstrated. There is no firm evidence that lead may be a cocarcinogen, although some limited experimental evidence is available. Oxidizing agents have been demonstrated to increase, and reducing agents to antagonize, the mutagenic effect of chromium compounds in vitro. The content of carcinogenic and other metals in asbestos has been suggested to modify the carcinogenic properties of asbestos. Since much of the information available at present is suggestive, further research on these interactions as well as other possible interactions in metal carcinogenesis is needed. Studies should be made both in well defined in vitro systems and in relevant animal models.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARONI C., VAN ESCHG, SAFFIOTTI U. CARCINOGENESIS TESTS OF TWO INORGANIC ARSENICALS. Arch Environ Health. 1963 Dec;7:668–674. doi: 10.1080/00039896.1963.10663598. [DOI] [PubMed] [Google Scholar]
  2. Barr D. H., Harris J. W. Growth of the P388 leukemia as an ascites tumor in zinc-deficient mice. Proc Soc Exp Biol Med. 1973 Oct 1;144(1):284–287. doi: 10.3181/00379727-144-37574. [DOI] [PubMed] [Google Scholar]
  3. Bauchinger M., Schmid E., Schmidt D. Chromosomenanalyse bei Verkehrspolizisten mit Erhöhter Bleilast. Mutat Res. 1972 Dec;16(4):407–412. doi: 10.1016/0027-5107(72)90209-6. [DOI] [PubMed] [Google Scholar]
  4. Beach D. J., Sunderman F. W., Jr Nickel carbonyl inhibition of 14C-orotic acid incorporation into rat liver RNA. Proc Soc Exp Biol Med. 1969 Jun;131(2):321–322. doi: 10.3181/00379727-131-33867. [DOI] [PubMed] [Google Scholar]
  5. Beach D. J., Sunderman F., Jr Nickel carbonyl inhibition of RNA synthesis by a chromatin-RNA polymerase complex from hepatic nuclei. Cancer Res. 1970 Jan;30(1):48–50. [PubMed] [Google Scholar]
  6. Beckman G., Beckman L., Nordenson I. Chromosome aberrations in workers exposed to arsenic. Environ Health Perspect. 1977 Aug;19:145–146. doi: 10.1289/ehp.7719145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Beek B., Obe G. Effect of lead acetate on human leukocyte chromosomes in vitro. Experientia. 1974 Sep 15;30(9):1006–1007. doi: 10.1007/BF01938974. [DOI] [PubMed] [Google Scholar]
  8. Bencko V. Carcinogenic, teratogenic, and mutagenic effects of arsenic. Environ Health Perspect. 1977 Aug;19:179–182. doi: 10.1289/ehp.7719179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Broghamer W. L., Jr, McConnell K. P., Grimaldi M., Blotcky A. J. Serum selenium and reticuloendothelial tumors. Cancer. 1978 Apr;41(4):1462–1466. doi: 10.1002/1097-0142(197804)41:4<1462::aid-cncr2820410434>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  10. Broghamer W. L., McConnell K. P., Blotcky A. L. Relationship between serum selenium levels and patients with carcinoma. Cancer. 1976 Mar;37(3):1384–1388. doi: 10.1002/1097-0142(197603)37:3<1384::aid-cncr2820370319>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  11. Cooper W. C., Gaffey W. R. Mortality of lead workers. J Occup Med. 1975 Feb;17(2):100–107. doi: 10.1097/00043764-197502000-00012. [DOI] [PubMed] [Google Scholar]
  12. Cralley L. J. Electromotive phenomenon in metal and mineral particulate exposures: relevance to exposure to asbestos and occurrence of cancer. Am Ind Hyg Assoc J. 1971 Oct;32(10):653–661. doi: 10.1080/0002889718506520. [DOI] [PubMed] [Google Scholar]
  13. DINGWALL-FORDYCE I., LANE R. E. A FOLLOW-UP STUDY OF LEAD WORKERS. Br J Ind Med. 1963 Oct;20:313–315. doi: 10.1136/oem.20.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. DeWys W., Pories W. Inhibition of a spectrum of animal tumors by dietary zinc deficiency. J Natl Cancer Inst. 1972 Feb;48(2):375–381. [PubMed] [Google Scholar]
  15. Deknudt G., Léonard A. Cytogenetic investigations on leucocytes of workers from a cadmium plant. Environ Physiol Biochem. 1975;5(5):319–327. [PubMed] [Google Scholar]
  16. Doll R., Morgan L. G., Speizer F. E. Cancers of the lung and nasal sinuses in nickel workers. Br J Cancer. 1970 Dec;24(4):623–632. doi: 10.1038/bjc.1970.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Duncan J. R., Dreosti I. E., Albrecht C. F. Zinc intake and growth of a transplanted hepatoma induced by 3'-methyl-4-dimethylaminoazobenzene in rats. J Natl Cancer Inst. 1974 Jul;53(1):277–278. doi: 10.1093/jnci/53.1.277. [DOI] [PubMed] [Google Scholar]
  18. Duncan J. R., Dreosti I. E. Zinc intake, neoplastic DNA synthesis, and chemical carcinogenesis in rats and mice. J Natl Cancer Inst. 1975 Jul;55(1):195–196. doi: 10.1093/jnci/55.1.195. [DOI] [PubMed] [Google Scholar]
  19. Edwards M. B. Chemical carcinogenesis in the cheek pouch of Syrian hamsters receiving supplementary zinc. Arch Oral Biol. 1976;21(2):133–135. doi: 10.1016/0003-9969(76)90084-4. [DOI] [PubMed] [Google Scholar]
  20. Exon J. H., Koller L. D., Elliott S. C. Effect of dietary selenium on tumor induction by an oncogenic virus. Clin Toxicol. 1976;9(2):273–279. doi: 10.3109/15563657608988130. [DOI] [PubMed] [Google Scholar]
  21. Factors influencing metabolism and toxicity of metals: a consensus report. Environ Health Perspect. 1978 Aug;25:3–41. doi: 10.1289/ehp.25-1637186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Feron V. J. Respiratory tract tumors in hamsters after intratracheal instillations of benzo(a)pyrene alone and with furfural. Cancer Res. 1972 Jan;32(1):28–36. [PubMed] [Google Scholar]
  23. Feron V. J., de Jong D., Emmelot P. Letter: Dose-response correlation for the induction of respiratory-tract tumours in Syrian golden hamsters by intratracheal instillations of benzo(a)pyrene. Eur J Cancer. 1973 May;9(5):387–390. doi: 10.1016/0014-2964(73)90057-1. [DOI] [PubMed] [Google Scholar]
  24. Fong L. Y., Sivak A., Newberne P. M. Zinc deficiency and methylbenzylnitrosamine-induced esophageal cancer in rats. J Natl Cancer Inst. 1978 Jul;61(1):145–150. doi: 10.1093/jnci/61.1.145. [DOI] [PubMed] [Google Scholar]
  25. GUNN S. A., GOULD T. C., ANDERSON W. A. CADMIUM-INDUCED INTERSTITIAL CELL TUMORS IN RATS AND MICE AND THEIR PREVENTION BY ZINC. J Natl Cancer Inst. 1963 Oct;31:745–759. [PubMed] [Google Scholar]
  26. GUNN S. A., GOULD T. C., ANDERSON W. A. EFFECT OF ZINC ON CANCEROGENESIS BY CADMIUM. Proc Soc Exp Biol Med. 1964 Mar;115:653–657. doi: 10.3181/00379727-115-28996. [DOI] [PubMed] [Google Scholar]
  27. Gabbiani G., Baic D., Déziel C. Studies on tolerance and ionic antagonism for cadmium or mercury. Can J Physiol Pharmacol. 1967 May;45(3):443–450. doi: 10.1139/y67-053. [DOI] [PubMed] [Google Scholar]
  28. Griffin A. C., Jacobs M. M. Effects of selenium on azo dye hepatocarcinogenesis. Cancer Lett. 1977 Sep;3(3-4):177–181. doi: 10.1016/s0304-3835(77)95431-3. [DOI] [PubMed] [Google Scholar]
  29. Gruber J. E., Jennette K. W. Metabolism of the carcinogen chromate by rat liver microsomes. Biochem Biophys Res Commun. 1978 May 30;82(2):700–706. doi: 10.1016/0006-291x(78)90931-2. [DOI] [PubMed] [Google Scholar]
  30. Gunn S. A., Gould T. C., Anderson W. A. Mechanisms of zinc, cysteine and selenium protection against cadmium induced vascular injury to mouse testis. J Reprod Fertil. 1968 Feb;15(1):65–70. doi: 10.1530/jrf.0.0150065. [DOI] [PubMed] [Google Scholar]
  31. Harr J. R., Exon J. H., Whanger P. D., Weswig P. H. Effect of dietary selenium on N-2 fluorenyl-acetamide (FAA)-induced cancer in vitamin E supplemented, selenium depleted rats. Clin Toxicol. 1972;5(2):187–194. doi: 10.3109/15563657208990998. [DOI] [PubMed] [Google Scholar]
  32. Henry M. C., Port C. D., Kaufman D. G. Importance of physical properties of benzo(a)pyrene-ferric oxide mixtures in lung tumor induction. Cancer Res. 1975 Jan;35(1):207–217. [PubMed] [Google Scholar]
  33. Ishinishi N., Kodama Y., Nobutomo K., Hisanaga A. Preliminary experimental study on carcinogenicity of arsenic trioxide in rat lung. Environ Health Perspect. 1977 Aug;19:191–196. doi: 10.1289/ehp.7719191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ito T., Sawauchi K. Inhibitory effects on cadmium-induced testicular damage by pretreatment with smaller cadmium dose. Okajimas Folia Anat Jpn. 1966 May;42(2):107–117. doi: 10.2535/ofaj1936.42.2-3_107. [DOI] [PubMed] [Google Scholar]
  35. Ivankovic S., Eisenbrand G., Preussmann R. Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int J Cancer. 1979 Dec 15;24(6):786–788. doi: 10.1002/ijc.2910240615. [DOI] [PubMed] [Google Scholar]
  36. Ivankovic S., Zeller W. J., Schmähl D. Steigerung der carcinogenen Wirkung von Athyl-nitrosoharnstoff durch Schwermetalle. Naturwissenschaften. 1972 Aug;59(8):369–369. doi: 10.1007/BF00617923. [DOI] [PubMed] [Google Scholar]
  37. Jacobs M. M., Jansson B., Griffin A. C. Inhibitory effects of selenium on 1,2-dimethylhydrazine and methylazoxymethanol acetate induction of colon tumors. Cancer Lett. 1977 Jan;2(3):133–137. doi: 10.1016/s0304-3835(77)80002-5. [DOI] [PubMed] [Google Scholar]
  38. Jacobs M. M., Matney T. S., Griffin A. C. Inhibitory effects of selenium of the mutagenicity of 2-acetylaminofluorene (AAF) and AAF derivatives. Cancer Lett. 1977 May;2(6):319–322. doi: 10.1016/s0304-3835(77)80011-6. [DOI] [PubMed] [Google Scholar]
  39. Jung E. G., Traschel B., Immich H. Arsenic as an inhibitor of the enzymes concerned in cellular recovery (dark repair). Ger Med Mon. 1969 Dec;14(12):614–616. [PubMed] [Google Scholar]
  40. Kang H. K., Infante P. F., Carra J. S. Occupational lead exposure and cancer. Science. 1980 Feb 29;207(4434):935–936. doi: 10.1126/science.7352298. [DOI] [PubMed] [Google Scholar]
  41. Kasprzak K. S., Marchow L., Breborowicz J. Pathological reactions in rat lungs following intratracheal injection of nickel subsulfide and 3,4-benzpyrene. Res Commun Chem Pathol Pharmacol. 1973 Jul;6(1):237–245. [PubMed] [Google Scholar]
  42. Kobayashi N., Okamoto T. Effects of lead oxide on the induction of lung tumors in Syrian hamsters. J Natl Cancer Inst. 1974 May;52(5):1605–1610. doi: 10.1093/jnci/52.5.1605. [DOI] [PubMed] [Google Scholar]
  43. Kreyberg L. Lung cancer in workers in a nickel refinery. Br J Ind Med. 1978 May;35(2):109–116. doi: 10.1136/oem.35.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Kroes R., van Logten M. J., Berkvens J. M., de Vries T., van Esch G. J. Study on the carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diethylnitrosamine. Food Cosmet Toxicol. 1974 Oct;12(5-6):671–679. doi: 10.1016/0015-6264(74)90238-7. [DOI] [PubMed] [Google Scholar]
  45. Kubota J., Lazar V. A., Losee F. Copper, zinc, cadmium, and lead in human blood from 19 locations in the United States. Arch Environ Health. 1968 Jun;16(6):788–793. doi: 10.1080/00039896.1968.10665153. [DOI] [PubMed] [Google Scholar]
  46. Lane B. P., Mass M. J. Carcinogenicity and cocarcinogenicity of chromium carbonyl in heterotopic tracheal grafts. Cancer Res. 1977 May;37(5):1476–1479. [PubMed] [Google Scholar]
  47. Lee A. M., Fraumeni J. F., Jr Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst. 1969 Jun;42(6):1045–1052. [PubMed] [Google Scholar]
  48. Lessard R., Reed D., Maheux B., Lambert J. Lung cancer in New Caledonia, a nickel smelting island. J Occup Med. 1978 Dec;20(12):815–817. [PubMed] [Google Scholar]
  49. Levander O. A. Metabolic interrelationships between arsenic and selenium. Environ Health Perspect. 1977 Aug;19:159–164. doi: 10.1289/ehp.7719159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Lo L. W., Koropatnick J., Stich H. F. The mutagenicity and cytotoxicity of selenite, "activated" selenite and selenate for normal and DNA repair-deficient human fibroblasts. Mutat Res. 1978 Mar;49(3):305–312. doi: 10.1016/0027-5107(78)90103-3. [DOI] [PubMed] [Google Scholar]
  51. Maenza R. M., Pradhan A. M., Sunderman F. W., Jr Rapid induction of sarcomas in rats by combination of nickel sulfide and 3,4-benzpyrene. Cancer Res. 1971 Dec;31(12):2067–2071. [PubMed] [Google Scholar]
  52. McConnell K. P., Broghamer W. L., Jr, Blotcky A. J., Hurt O. J. Selenium levels in human blood and tissues in health and in disease. J Nutr. 1975 Aug;105(8):1026–1031. doi: 10.1093/jn/105.8.1026. [DOI] [PubMed] [Google Scholar]
  53. McQuitty J. T., Jr, DeWys W. D., Monaco L., Strain W. H., Rob C. G., Apgar J., Pories W. J. Inhibition of tumor growth by dietary zinc deficiency. Cancer Res. 1970 May;30(5):1387–1390. [PubMed] [Google Scholar]
  54. Milner J. E. The effect of ingested arsenic on methylcholanthrene-induced skin tumors in mice. Arch Environ Health. 1969 Jan;18(1):7–11. doi: 10.1080/00039896.1969.10665366. [DOI] [PubMed] [Google Scholar]
  55. Moutschen J., Degraeve N. Influence of thiol-inhibiting substances on the effects of ethyl methane sulphonate (EMS) on chromosomes. Experientia. 1965 Apr 15;21(4):200–202. doi: 10.1007/BF02141884. [DOI] [PubMed] [Google Scholar]
  56. Nakamuro K., Yoshikawa K., Sayato Y., Kurata H. Comparative studies of chromosomal aberration and mutagenicity of the trivalent and hexavalent chromium. Mutat Res. 1978 Nov;58(2-3):175–181. doi: 10.1016/0165-1218(78)90007-1. [DOI] [PubMed] [Google Scholar]
  57. Nakamuro K., Yoshikawa K., Sayato Y., Kurata H., Tonomura M. Studies on selenium-related compounds. V. Cytogenetic effect and reactivity with DNA. Mutat Res. 1976 Jul;40(3):177–184. doi: 10.1016/0165-1218(76)90042-2. [DOI] [PubMed] [Google Scholar]
  58. Nettesheim P., Creasia D. A., Mitchell T. J. Carcinogenic and cocarcinogenic effects of inhaled synthetic smog and ferric oxide particles. J Natl Cancer Inst. 1975 Jul;55(1):159–169. doi: 10.1093/jnci/55.1.159. [DOI] [PubMed] [Google Scholar]
  59. Nishioka H. Mutagenic activities of metal compounds in bacteria. Mutat Res. 1975 Jun;31(3):185–189. doi: 10.1016/0165-1161(75)90088-6. [DOI] [PubMed] [Google Scholar]
  60. Noda M., Takano T., Sakurai H. Mutagenic activity of selenium compounds. Mutat Res. 1979 Feb;66(2):175–179. doi: 10.1016/0165-1218(79)90063-6. [DOI] [PubMed] [Google Scholar]
  61. Nordenson I., Beckman G., Beckman L., Nordström S. Occupational and environmental risks in and around a smelter in northern Sweden. IV. Chromosomal aberrations in workers exposed to lead. Hereditas. 1978;88(2):263–267. doi: 10.1111/j.1601-5223.1978.tb01628.x. [DOI] [PubMed] [Google Scholar]
  62. Norseth T. The carcinogenicity of chromium. Environ Health Perspect. 1981 Aug;40:121–130. doi: 10.1289/ehp.8140121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. O'Riordan M. L., Hughes E. G., Evans H. J. Chromosome studies on blood lymphocytes of men occupationally exposed to cadmium. Mutat Res. 1978 Nov;58(2-3):305–311. doi: 10.1016/0165-1218(78)90023-x. [DOI] [PubMed] [Google Scholar]
  64. Oppenheim J. J., Fishbein W. N. Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds. Cancer Res. 1965 Aug;25(7):980–985. [PubMed] [Google Scholar]
  65. Paton G. R., Allison A. C. Chromosome damage in human cell cultures induced by metal salts. Mutat Res. 1972 Nov;16(3):332–336. doi: 10.1016/0027-5107(72)90166-2. [DOI] [PubMed] [Google Scholar]
  66. Pershagen G., Elinder C. G., Bolander A. M. Mortality in a region surrounding an arsenic emitting plant. Environ Health Perspect. 1977 Aug;19:133–137. doi: 10.1289/ehp.7719133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Pershagen G. The carcinogenicity of arsenic. Environ Health Perspect. 1981 Aug;40:93–100. doi: 10.1289/ehp.814093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Petering H. G., Buskirk H. H., Crim J. A. The effect of dietary mineral supplements of the rat on the antitumor activity of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazone). Cancer Res. 1967 Jun;27(6):1115–1121. [PubMed] [Google Scholar]
  69. Petres J., Baron D., Hagedorn M. Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ Health Perspect. 1977 Aug;19:223–227. doi: 10.1289/ehp.7719223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Petrilli F. L., De Flora S. Metabolic deactivation of hexavalent chromium mutagenicity. Mutat Res. 1978 Oct;54(2):139–147. doi: 10.1016/0165-1161(78)90034-1. [DOI] [PubMed] [Google Scholar]
  71. Petrilli F. L., de Flora S. Oxidation of inactive trivalent chromium to the mutagenic hexavalent form. Mutat Res. 1978 Nov;58(2-3):167–173. doi: 10.1016/0165-1218(78)90006-x. [DOI] [PubMed] [Google Scholar]
  72. Phillips J. L., Sheridan P. J. Effect of zinc administration on the growth of L1210 and BW5147 tumors in mice. J Natl Cancer Inst. 1976 Aug;57(2):361–363. doi: 10.1093/jnci/57.2.361. [DOI] [PubMed] [Google Scholar]
  73. Piscator M. Role of cadmium in carcinogenesis with special reference to cancer of the prostate. Environ Health Perspect. 1981 Aug;40:107–120. doi: 10.1289/ehp.8140107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Poswillo D. E., Cohen B. Inhibition of carcinogenesis by dietary zinc. Nature. 1971 Jun 18;231(5303):447–448. doi: 10.1038/231447a0. [DOI] [PubMed] [Google Scholar]
  75. Ray J. H., Altenburg L. C. Sister-chromatid exchange induction by sodium selenite: dependence on the presence of red blood cells or red blood cell lysate. Mutat Res. 1978 Dec;54(3):343–354. doi: 10.1016/0165-1161(78)90024-9. [DOI] [PubMed] [Google Scholar]
  76. Riley J. F. Mast cells, co-carcinogenesis and anti-carcinogenesis in the skin of mice. Experientia. 1968 Dec 15;24(12):1237–1238. doi: 10.1007/BF02146643. [DOI] [PubMed] [Google Scholar]
  77. Rosen P. Theoretical significance of arsenic as a carcinogen. J Theor Biol. 1971 Aug;32(2):425–426. doi: 10.1016/0022-5193(71)90178-0. [DOI] [PubMed] [Google Scholar]
  78. Rossman T. G., Meyn M. S., Troll W. Effects of arsenite on DNA repair in Escherichia coli. Environ Health Perspect. 1977 Aug;19:229–233. doi: 10.1289/ehp.7719229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Saffiotti U., Cefis F., Kolb L. H. A method for the experimental induction of bronchogenic carcinoma. Cancer Res. 1968 Jan;28(1):104–124. [PubMed] [Google Scholar]
  80. Saffiotti U., Montesano R., Sellakumar A. R., Cefis F., Kaufman D. G. Respiratory tract carcinogenesis in hamsters induced by different numbers of administrations of benzo(a)pyrene and ferric oxide. Cancer Res. 1972 May;32(5):1073–1081. [PubMed] [Google Scholar]
  81. Saffiotti U., Montesano R., Sellakumar A. R., Kaufman D. G. Respiratory tract carcinogenesis induced in hamsters by different dose levels of benzo-(a)pyrene and ferric oxide. J Natl Cancer Inst. 1972 Oct;49(4):1199–1204. [PubMed] [Google Scholar]
  82. Schmid E., Bauchinger M., Pietruck S., Hall G. Die Cytogenetische Wirkung von Blei in Menschlichen peripheren Lymphocyten in vitro und in vivo. Mutat Res. 1972 Dec;16(4):401–406. doi: 10.1016/0027-5107(72)90208-4. [DOI] [PubMed] [Google Scholar]
  83. Schnell R. C., Means J. R., Roberts S. A., Pence D. H. Studies on cadmium-induced inhibition of hepatic microsomal drug biotransformation in the rat. Environ Health Perspect. 1979 Feb;28:273–279. doi: 10.1289/ehp.7928273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Schrauzer G. N., Ishmael D. Effects of selenium and of arsenic on the genesis of spontaneous mammary tumors in inbred C3H mice. Ann Clin Lab Sci. 1974 Nov-Dec;4(6):441–447. [PubMed] [Google Scholar]
  85. Schrauzer G. N., White D. A., Schneider C. J. Cancer mortality correlation studies--III: statistical associations with dietary selenium intakes. Bioinorg Chem. 1977;7(1):23–31. doi: 10.1016/s0006-3061(00)80126-x. [DOI] [PubMed] [Google Scholar]
  86. Schrauzer G. N., White D. A., Schneider C. J. Cancer mortality correlation studies--IV: associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists. Bioinorg Chem. 1977;7(1):35–56. doi: 10.1016/s0006-3061(00)80127-1. [DOI] [PubMed] [Google Scholar]
  87. Schrauzer G. N., White D. A., Schneider C. J. Inhibition of the genesis of spontaneous mammary tumors in C3H mice: effects of selenium and of selenium-antagonistic elements and their possible role in human breast cancer. Bioinorg Chem. 1976;6(3):265–270. doi: 10.1016/s0006-3061(00)80232-x. [DOI] [PubMed] [Google Scholar]
  88. Shamberger R. J., Baughman F. F., Kalchert S. L., Willis C. S., Hoffman G. C. Carcinogen-induced chromosomal breakage decreased by antioxidants. Proc Natl Acad Sci U S A. 1973 May;70(5):1461–1463. doi: 10.1073/pnas.70.5.1461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Shamberger R. J. Relationship of selenium to cancer. I. Inhibitory effect of selenium on carcinogenesis. J Natl Cancer Inst. 1970 Apr;44(4):931–936. [PubMed] [Google Scholar]
  90. Shamberger R. J., Rudolph G. Protection against cocarcinogenesis by antioxidants. Experientia. 1966 Feb 15;22(2):116–116. doi: 10.1007/BF01900187. [DOI] [PubMed] [Google Scholar]
  91. Shamberger R. J., Rukovena E., Longfield A. K., Tytko S. A., Deodhar S., Willis C. E. Antioxidants and cancer. I. Selenium in the blood of normals and cancer patients. J Natl Cancer Inst. 1973 Apr;50(4):863–870. doi: 10.1093/jnci/50.4.863. [DOI] [PubMed] [Google Scholar]
  92. Shamberger R. J., Tytko S. A., Willis C. E. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health. 1976 Sep-Oct;31(5):231–235. doi: 10.1080/00039896.1976.10667225. [DOI] [PubMed] [Google Scholar]
  93. Shamberger R. J., Willis C. E. Selenium distribution and human cancer mortality. CRC Crit Rev Clin Lab Sci. 1971 Jun;2(2):211–221. doi: 10.3109/10408367109151308. [DOI] [PubMed] [Google Scholar]
  94. Stenbäck F. G., Ferrero A., Shubik P. Synergistic effects of diethylnitrosamine and different dusts on respiratory carcinogenesis in hamsters. Cancer Res. 1973 Oct;33(10):2209–2214. [PubMed] [Google Scholar]
  95. Stenbäck F., Sellakumar A., Shubik P. Magnesium oxide as carrier dust in benzo(a)pyrene-induced lung carcino-genesis in Syrian hamsters. J Natl Cancer Inst. 1975 Apr;54(4):861–867. [PubMed] [Google Scholar]
  96. Sunderman F. W., Jr Inhibition of induction of benzpyrene hydroxylase by nickel carbonyl. Cancer Res. 1967 May;27(5):950–955. [PubMed] [Google Scholar]
  97. Sunderman F. W., Jr, Kasprzak K. S., Lau T. J., Minghetti P. P., Maenza R. M., Becker N., Onkelinx C., Goldblatt P. J. Effects of manganese on carcinogenicity and metabolism of nickel subsulfide. Cancer Res. 1976 May;36(5):1790–1800. [PubMed] [Google Scholar]
  98. Sunderman F. W., Jr, Lau T. J., Cralley L. J. Inhibitory effect of manganese upon muscle tumorigenesis by nickel subsulfide. Cancer Res. 1974 Jan;34(1):92–95. [PubMed] [Google Scholar]
  99. Sunderman F. W., Jr Nickel carbonyl inhibition of phenobarbital induction of hepatic cytochrome P-450. Cancer Res. 1968 Mar;28(3):465–470. [PubMed] [Google Scholar]
  100. Sunderman F. W., Jr Recent research on nickel carcinogenesis. Environ Health Perspect. 1981 Aug;40:131–141. doi: 10.1289/ehp.8140131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Thomson R., Kilroe-Smith T. A., Webster I. The effect of asbestos-associated metal ions on the binding of benzo(a)pyrene to macromolecules in vitro. Environ Res. 1978 Apr;15(2):309–319. doi: 10.1016/0013-9351(78)90106-8. [DOI] [PubMed] [Google Scholar]
  102. Tsuda H., Kato K. Potassium dichromate-induced chromosome aberrations and its control with sodium sulfite in hamster embryonic cells in vitro. Gan. 1976 Jun;67(3):469–470. [PubMed] [Google Scholar]
  103. Walker G. W., Bradley A. M. Interacting effects of sodium monohydrogenarsenate and selenocystine on crossing over in Drosophila melanogaster. Can J Genet Cytol. 1969 Sep;11(3):677–688. doi: 10.1139/g69-081. [DOI] [PubMed] [Google Scholar]
  104. Wehner A. P., Busch R. H., Olson R. J., Craig D. K. Chronic inhalation of nickel oxide and cigarette smoke by hamsters. Am Ind Hyg Assoc J. 1975 Nov;36(11):801–810. doi: 10.1080/0002889758507346. [DOI] [PubMed] [Google Scholar]
  105. Zeller W. J., Ivankovic S. Steigerung der toxischen Wirkung von Alkylnitrosoharnstoffen durch Schwermetalle. Naturwissenschaften. 1972 Feb;59(2):82–82. doi: 10.1007/BF00593478. [DOI] [PubMed] [Google Scholar]
  106. Zeller W. J. Untersuchungen zum Einfluss von Kupfer- und Kobaltionen auf die Karzinogenese durch Diäthylnitrosamin (DANA) bei Wistar-Ratten. Arch Geschwulstforsch. 1975;45(7):634–636. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES